Target intelligence / Profile preview

Penicillin-binding protein 1A and Penicillin-binding protein 1B (PBP1A and PBP1B)

Target
PBP1A and PBP1B
Molecular classification
Enzyme, Glycosyltransferase, Transpeptidase, High-molecular-weight penicillin-binding protein
01

Overview

Penicillin-binding protein 1A (PBP1A) and Penicillin-binding protein 1B (PBP1B) are essential high-molecular-weight Class A enzymes involved in the final stages of bacterial peptidoglycan biosynthesis [1, 3]. These bifunctional proteins possess both glycosyltransferase activity, which polymerizes glycan strands, and transpeptidase activity, which cross-links peptide side chains to provide structural integrity to the cell wall [7, 10]. In many bacteria, such as Escherichia coli, PBP1A and PBP1B exhibit functional redundancy; while neither is individually essential, the loss of both is lethal to the cell [11, 14]. PBP1A is typically associated with the elongasome complex for cell wall expansion, whereas PBP1B is often localized to the divisome to facilitate cell division [1, 19]. As the primary targets for beta-lactam antibiotics, these proteins are inhibited when the drug covalently binds to the active-site serine of the transpeptidase domain, leading to cell wall weakening and osmotic lysis [6, 9]. Resistance to these agents frequently develops through mutations in the pbp genes (e.g., ponA, ponB) that reduce antibiotic binding affinity or through the enzymatic degradation of drugs by beta-lactamases [1, 15].

Other names
mrcAmrcBponAponBClass A PBPsBifunctional transglycosylase/transpeptidaseHigh-molecular-weight penicillin-binding proteins
02

Mechanism of action

Inhibition of the transpeptidase domain through covalent binding to the active-site serine, preventing peptidoglycan cross-linking, and/or inhibition of the glycosyltransferase domain, preventing glycan strand polymerization.

03

Biological functions

Peptidoglycan biosynthesisCell wall assemblyCell elongationCell divisionMaintenance of cell shape and integrity
04

Disease associations

Infection
05

Safety considerations

Antibiotic resistance (via PBP mutations or beta-lactamase production)Hypersensitivity and allergic reactionsGut microbiome disruption (dysbiosis)Jarisch-Herxheimer reaction
06

Interacting drugs

Benzylpenicillin

10 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)PBP occupancyPeptidoglycan cross-linking levelsBacterial growth inhibition

Beyond the preview

Go deeper on Penicillin-binding protein 1A and Penicillin-binding protein 1B (PBP1A and PBP1B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Penicillin-binding protein 1A and Penicillin-binding protein 1B (PBP1A and PBP1B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call